NUVO PHARMACEUTICALS IRELAND DESIGNATED ACTIVITY COMPANY LLC v. Lupin Ltd., Lupin Pharmaceuticals, Inc., Defendants-Appellants (2019)

United States Court of Appeals, Federal Circuit.

NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY, Horizon Medicines LLC, Plaintiffs-Appellees v. DR. REDDY'S LABORATORIES INC., Dr. Reddy's Laboratories, Ltd., Mylan, Inc., Mylan Pharmaceuticals Inc., Mylan Laboratories Limited, Defendants Lupin Ltd., Lupin Pharmaceuticals, Inc., Defendants-Appellants

2017-2487, 2017-2488

Decided: August 07, 2019

Before Prost, Chief Judge, Clevenger and Wallach, Circuit Judges. James B. Monroe, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for plaintiffs-appellees. Plaintiff-appellee Horizon Medicines LLC also represented by Charles Collins-Chase. Stephen M. Hash, Baker Botts, LLP, Austin, TX, for plaintiff-appellee Nuvo Pharmaceuticals (Ireland) Designated Activity Company. Also represented by Jeffrey Sean Gritton. Sailesh K. Patel, Schiff Hardin LLP, Chicago, IL, for defendants-appellants.

Lupin Ltd. (Appeal No. 2017-2487) and Lupin Pharmaceuticals, Inc. (Appeal No. 2017-2488) appeal from the final judgment of the United States District Court for the District of New Jersey. Horizon Pharma, Inc. v. Lupin Ltd., No. 3:11-cv-04275-MCL-DEA (D.N.J. July 21, 2017) (final judgment). That final judgment sustained the validity of U.S. Patent Nos. 6,926,907 (“the ’907 patent”) and 8,557,285 (“the ’285 patent”), and found the appellants in-fringed those patents.

The appellants assert that the district court erred in sustaining the validity of the ’907 and ’285 patents, and consequently erred in the judgment of infringement. The appellants are correct. In Nuvo Pharmaceuticals (Ireland) Designated Activity Company v. Dr. Reddy’s Laboratories Inc., 923 F.3d 1368 (Fed. Cir. 2019), this court held that the ’907 and ’285 patents are invalid for failure to satisfy the written description requirement in 35 U.S.C. § 112(a). The patents asserted against the appellants are invalid. The final judgment of the district court against the appellants is reversed.

REVERSED

Costs

No costs.

Per Curiam.